UNSPSC 51342307: Penciclovir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C10H15N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 359HUE8FJC, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)butyl)- & human interferon-.gamma. but generally known as penciclovir, which bears US NIH Compound Identifier 4725. European Medicines Agency schedules Penciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09661MIG.

UNSPSC 51342307 Penciclovir is a Commodity code that shows minimal relevant recent activity under its nominal scope. The four recent state and local opportunities tagged to this code—naloxone and drug deactivation systems procurement, a therapeutic pharmacy initiative RFI, medical and first aid supplies for fire rescue, and a multistate cooperative pharmaceutical purchasing contract—represent naloxone, emergency medical supplies, and generic pharmaceuticals, none of which align with penciclovir (an antiviral medication for herpes infections). The mismatch suggests either miscoding in the opportunities database or that penciclovir procurement does not generate substantial state and local RFP, RFQ, IFB, or ITB activity at present.

No state and local contract opportunities for penciclovir specifically appear in the recent-activity block. Pursue alternative codes or commodity families if antiviral pharmaceuticals or broader pharmacy procurement are the target; the current code shows no actionable pipeline under its stated scope.